describe the three phases of the normal blood clotting process
blood coagulation vasoconstriction,
title: Clotting time text: Clotting time Clotting time is the time required for a sample of blood to coagulate in vitro under standard conditions. There are various methods for determining the clotting time, the most common being the capillary tube method. It is affected by calcium ion levels and many diseases. Normal value of clotting time is 8 to 15 minutes. For the measurement of clotting time by test tube method, blood is placed in a glass test tube and kept at 37° C. The required time is measured for the blood to clot. There are several other methods, including testing for those on title: Clotting time text: blood thinners, such as heparin or warfarin. Activated partial thromboplastin time (aPTT) is used for heparin studies and the normal range is 20–36 seconds, depending upon which type of activator is used in the study. Prothrombin time (PT) is used for warfarin studies and the normal values differ for men and women. PT time for adult males' normal range is 9.6–11.8 seconds, while adult females' normal range is 9.5–11.3 seconds. Internationalized normalized ratio (INR) is also a warfarin study, with normal ranges of 2–3 for standard warfarin and 3–4.5 for high-dose warfarin. Clotting time Clotting time is the time required title: Coagulation text: Coagulation Coagulation (also known as clotting) is the process by which blood changes from a liquid to a gel, forming a blood clot. It potentially results in hemostasis, the cessation of blood loss from a damaged vessel, followed by repair. The mechanism of coagulation involves activation, adhesion, and aggregation of platelets along with deposition and maturation of fibrin. Disorders of coagulation are disease states which can result in bleeding (hemorrhage or bruising) or obstructive clotting (thrombosis). Coagulation begins almost instantly after an injury to the blood vessel has damaged the endothelium lining the vessel. Exposure of blood to the subendothelial title: Hemostasis text: the body to stop bleeding and loss of blood. During hemostasis three steps occur in a rapid sequence. Vascular spasm is the first response as the blood vessels constrict to allow less blood to be lost. In the second step, platelet plug formation, platelets stick together to form a temporary seal to cover the break in the vessel wall. The third and last step is called coagulation or blood clotting. Coagulation reinforces the platelet plug with fibrin threads that act as a "molecular glue". Platelets are a large factor in the hemostatic process. They allow for the creation of the title: Fibrinolysis text: Fibrinolysis Fibrinolysis is a process that prevents blood clots from growing and becoming problematic. This process has two types: primary fibrinolysis and secondary fibrinolysis. The primary type is a normal body process, whereas secondary fibrinolysis is the breakdown of clots due to a medicine, a medical disorder, or some other cause. In fibrinolysis, a fibrin clot, the product of coagulation, is broken down. Its main enzyme plasmin cuts the fibrin mesh at various places, leading to the production of circulating fragments that are cleared by other proteases or by the kidney and liver. Plasmin is produced in an inactive form,